Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Clinical Investigations

  • You have access
    PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
    Clemens Kratochwil, Frederik L. Giesel, Melsa Stefanova, Martina Benešová, Marcus Bronzel, Ali Afshar-Oromieh, Walter Mier, Matthias Eder, Klaus Kopka and Uwe Haberkorn
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1170-1176; DOI: https://doi.org/10.2967/jnumed.115.171397
  • You have access
    Clinical Evaluation of 99mTc-Rituximab for Sentinel Lymph Node Mapping in Breast Cancer Patients
    Nan Li, Xuejuan Wang, Baohe Lin, Hua Zhu, Cheng Liu, Xiaobao Xu, Yan Zhang, Shizhen Zhai, Tao OuYang, Jinfeng Li and Zhi Yang
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1214-1220; DOI: https://doi.org/10.2967/jnumed.115.160572
  • You have access
    Supraclavicular Brown Adipose Tissue 18F-FDG Uptake and Cardiovascular Disease
    Richard A.P. Takx, Amorina Ishai, Quynh A. Truong, Meghan H. MacNabb, Marielle Scherrer-Crosbie and Ahmed Tawakol
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1221-1225; DOI: https://doi.org/10.2967/jnumed.115.166025
  • You have access
    Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT
    Shigeto Ueda, Nobuko Yoshizawa, Takashi Shigekawa, Hideki Takeuchi, Hiroyuki Ogura, Akihiko Osaki, Toshiaki Saeki, Yukio Ueda, Tomohiko Yamane, Ichiei Kuji and Harumi Sakahara
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1189-1195; DOI: https://doi.org/10.2967/jnumed.115.167320
  • You have access
    Assessment of Minimum 124I Activity Required in Uptake Measurements Before Radioiodine Therapy for Benign Thyroid Diseases
    Anja S. Gabler, Christian Kühnel, Thomas Winkens and Martin Freesmeyer
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1201-1206; DOI: https://doi.org/10.2967/jnumed.115.171066
  • You have access
    99mTc-Glu-c(RGDyK)-Bombesin SPECT Can Reduce Unnecessary Biopsy of Masses That Are BI-RADS Category 4 on Ultrasonography
    Tiefeng Ji, Shi Gao, Zhaofei Liu, Hua Xing, Guoqing Zhao and Qingjie Ma
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1196-1200; DOI: https://doi.org/10.2967/jnumed.115.168773
  • You have access
    Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis
    Donatienne Van Weehaeghe, Jenny Ceccarini, Aline Delva, Wim Robberecht, Philip Van Damme and Koen Van Laere
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1238-1243; DOI: https://doi.org/10.2967/jnumed.115.166272
  • You have access
    Impact of Appropriate Use on the Estimated Radiation Risk to Men and Women Undergoing Radionuclide Myocardial Perfusion Imaging
    Rami Doukky, Nathan Frogge, Andrew Appis, Kathleen Hayes, George Khoudary, Louis Fogg and Kim A. Williams
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1251-1257; DOI: https://doi.org/10.2967/jnumed.115.167205
  • You have access
    89Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel–Lindau Disease
    Sjoukje F. Oosting, Sophie J. van Asselt, Adrienne H. Brouwers, Alfons H.H. Bongaerts, Julia D.J. Steinberg, Johan R. de Jong, Marjolijn N. Lub-de Hooge, Anouk N.A. van der Horst-Schrivers, Annemiek M.E. Walenkamp, Eelco W. Hoving, Wim J. Sluiter, Bernard A. Zonnenberg, Elisabeth G.E. de Vries and Thera P. Links
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1244-1250; DOI: https://doi.org/10.2967/jnumed.115.167643
  • You have access
    The Prognostic Impact of Early Change in 18F-FDG PET SUV After Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer
    Hak Woo Lee, Hak Min Lee, Sung-Eun Choi, Hanna Yoo, Sung Gwe Ahn, Min Kyung Lee, Joon Jeong and Woo-Hee Jung
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1183-1188; DOI: https://doi.org/10.2967/jnumed.115.166322

Pages

  • Previous
  • Next
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 201
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire